Oestrogen receptive positive breast cancer can be treated by drugs, such as fulvestrant, that interfere with the action of oestrogen.
Category: Hormone therapy
A new method to select the right treatment for advanced prostate cancer
Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal
Study finds patient messages help predict medication adherence
Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be
Breast cancer can be dormant for years
Breast cancer can return 20 years after a woman is first diagnosed, women might be told to continue taking hormonal
Hormone replacement therapy may increase risk of hearing loss
Hearing loss is inability to hear sounds of 25 decibels or under in speech. This often leads to difficulties understanding
